Physician profile
Ivan A Ramos
NPI 1457337552
$2,154.00
in general payments reported to CMS, 2019-2025
18 companies · $24.08 in 2025
The $24.08 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $916 · 2021: $373 · 2022: $78.26 · 2023: $40.00 · 2024: $54.70 · 2025: $24.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $610.11 | 2019-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $350.35 | 2019-2021 | |
| Astellas Pharma US INC | $161.92 | 2020-2021 | |
| Pfizer INC. | $141.32 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.65 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $131.00 | 2019-2020 | |
| Lilly USA, LLC | $113.75 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $87.72 | 2019-2020 | |
| Allergan, INC. | $62.98 | 2020 | |
| Nestle Healthcare Nutrition INC. | $61.42 | 2021 | |
| Amgen INC. | $57.84 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $56.06 | 2020-2021 | |
| Amarin Pharma, INC. | $45.97 | 2019-2021 | |
| Smith+Nephew, INC. | $44.08 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.06 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.90 | 2021 | |
| Edwards Lifesciences Corporation | $19.15 | 2020 | |
| Esperion Therapeutics, INC. | $16.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.